Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kyntra Bio (KYNB) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Kyntra Bio (KYNB) over the last 12 years, with Q3 2025 value amounting to $49.61.

  • Kyntra Bio's EPS (Basic) rose 51307.24% to $49.61 in Q3 2025 from the same period last year, while for Sep 2025 it was $80.73, marking a year-over-year increase of 41959.62%. This contributed to the annual value of $1.05 for FY2024, which is 16492.85% up from last year.
  • According to the latest figures from Q3 2025, Kyntra Bio's EPS (Basic) is $49.61, which was up 51307.24% from -$3.38 recorded in Q2 2025.
  • Over the past 5 years, Kyntra Bio's EPS (Basic) peaked at $49.61 during Q3 2025, and registered a low of -$12.01 during Q3 2024.
  • Over the past 5 years, Kyntra Bio's median EPS (Basic) value was -$0.78 (recorded in 2021), while the average stood at $1.74.
  • Examining YoY changes over the last 5 years, Kyntra Bio's EPS (Basic) showed a top increase of 97522.76% in 2024 and a maximum decrease of 174769.23% in 2024.
  • Quarter analysis of 5 years shows Kyntra Bio's EPS (Basic) stood at -$1.45 in 2021, then soared by 51.03% to -$0.71 in 2022, then crashed by 34.52% to -$0.96 in 2023, then surged by 127.88% to $0.27 in 2024, then soared by 18525.67% to $49.61 in 2025.
  • Its last three reported values are $49.61 in Q3 2025, -$3.38 for Q2 2025, and $0.21 during Q1 2025.